10% Free customization
European medical diagnostics market is expected to reach US$109.91 billion in 2028, growing at a CAGR of 5.69%, for the time period of 2024-2028. Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market. However the market growth would be challenged by lack of skilled professionals, high cost of infectious diseases diagnosis and stringent government regulations. A few notable trends mat include, emerging role of precision medicine, emergence of various pandemic diseases and demand for point-of-care (POC) tests. This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Based on technology, the market has been segmented into immunoassays, clinical chemistry, haematology and coagulation. With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. As a result of this, the demand for immunoassays is rising, which is aiding the market growth of medical diagnostics in Europe.
Based on country, the market has been segmented into Germany, the U.K., France and Rest of Europe. Due to the continuous collaboration and partnerships between diagnostics companies, along with the expansion of the healthcare infrastructure, Germany continues to be the dominant country, which is capturing significant share in the medical diagnostics market in Europe.
Scope of the report
- The report provides a comprehensive analysis of the European Medical Diagnostics Market.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The company profiles of leading players (Labcorp, Quest Diagnostics, Sonic Healthcare, Eurofins Scientific, Synlab and Medicover) are also presented in detail.
Key Target Audience
- Diagnostic Devices Manufacturers
- Medical Technology Firms
- End Users (Hospitals, Clinics, Emergency Centers, Home care, etc.)
- Investment Banks
- Healthcare and Medical Consultants
- Government Bodies & Regulating Authorities
Please note: 10% free customization equates to up to 3 hours of analyst time.
Table of Contents
1. Overview
2. Impact of COVID-19
3. Europe Market Analysis
4. Market Dynamics
5. Company Profiles
List of Charts
List of Tables
Companies Mentioned
- Medicover
- Synlab
- Eurofins Scientific
- Sonic Healthcare
- Quest Diagnostics
- Labcorp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 61 |
| Published | March 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 88.1 Billion |
| Forecasted Market Value ( USD | $ 109.91 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 6 |
![Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031 - Product Image](http://www.researchandmarkets.com/product_images/12622/12622545_60px_jpg/europe_cancer_diagnostics_market.jpg)
![In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12002/12002788_60px_jpg/invitro_diagnostics_market.jpg)
